Skip to main content

Biogen Inc (BIIB-Q) Quote

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 277.11
Day High 283.95
Open:278.25
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Biogen Inc Rises 28.48% on Heavy Volume: Watch For Potential Pullback
- Comtex SmarTrend(R) - Tue Nov 12, 10:50AM CST
Comtex SmarTrend(R) - CMTX
Tue Nov 12, 10:50AM CST
Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $289.12 to a high of $296.25. Yesterday, the shares gained 28.5%, which took the trading range above the 3-day high of $294.92 on volume of 627,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for Biogen Inc to Potentially Pullback After Gaining 28.48% Yesterday
- Comtex SmarTrend(R) - Tue Nov 12, 10:50AM CST
Comtex SmarTrend(R) - CMTX
Tue Nov 12, 10:50AM CST
Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $289.12 to a high of $296.25. Yesterday, the shares gained 28.5%, which took the trading range above the 3-day high of $294.92 on volume of 627,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Alkermes Announces Receipt of $150 Million Milestone Payment from Biogen Related to FDA Approval of VUMERITY(TM)
- PR Newswire - Tue Nov 12, 6:00AM CST
PR Newswire - CMTX
Tue Nov 12, 6:00AM CST
Alkermes plc (Nasdaq: ALKS) today announced the receipt of a $150 million milestone payment from Biogen triggered by the recent U.S. Food and Drug Administration (FDA) approval of VUMERITY(TM) (diroximel fumarate), a novel oral fumarate with a distinct chemical structure, for the treatment of relapsing forms of multiple sclerosis, and Alkermes' transfer to Biogen Inc. (Nasdaq: BIIB) of the New Drug Application and other regulatory documentation related to VUMERITY.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 220.01 +28.30% increase
on 10/18/19
Period Open:226.06
Price movement based on the high, low and last over the given period.
318.00 -11.24% decrease
on 10/22/19
+56.21 (+24.87%) increase
since 10/15/19
3-Month 215.77 +30.82% increase
on 09/04/19
Period Open:227.63
Price movement based on the high, low and last over the given period.
318.00 -11.24% decrease
on 10/22/19
+54.64 (+24.00%) increase
since 08/15/19
52-Week 215.77 +30.82% increase
on 09/04/19
Period Open:321.72
Price movement based on the high, low and last over the given period.
344.00 -17.94% decrease
on 01/23/19
-39.45 (-12.26%) decrease
since 11/15/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).